Two Sigma Securities, LLC Novavax Inc Call Options Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$36.28 - $75.29 $333,776 - $692,668
9,200 Added 19.45%
56,500 $2.91 Million
Q1 2022

May 16, 2022
BUY
$69.73 - $142.9 $2.06 Million - $4.23 Million
29,600 Added 167.23%
47,300 $3.48 Million
Q3 2021

Nov 15, 2021
BUY
$177.8 - $270.58 $2.12 Million - $3.22 Million
11,900 Added 205.17%
17,700 $3.67 Million
Q2 2021

Aug 16, 2021
BUY
$121.0 - $257.67 $701,800 - $1.49 Million
5,800 New
5,800 $1.23 Million

Others Institutions Holding NVAX

# of Institutions
292
Shares Held
93.4M
Call Options Held
6.95M
Put Options Held
9.4M
View Full List

About NOVAVAX INC

NVAX Quotes by TradingView
  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $662M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email